NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Redcliffe Labs Sells Fertility Services Business to MMG Group's Healthcare Arm

Diagnostic chain Redcliffe Labs has announced that it is selling its fertility services business, Crysta IVF, to Moon Care Private Limited, the healthcare arm of the MMG Group, as per a press statement issued on April 9.

The transaction reflects Redcliffe Labs' continued focus on strengthening its diagnostics capabilities and expanding its presence in preventive and advanced diagnostic services across India. The move allows the organization to consolidate further its efforts to deliver technology-led accessible, accurate, and affordable diagnostic solutions at scale.

While financial details of the transaction were not disclosed, sources told Moneycontrol that the deal is valued at around Rs 100 crore. This strategic move enables Redcliffe Labs to sharpen its focus on building a strong, accessible diagnostics ecosystem rooted in preventive healthcare.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Redcliffe Labs' Founder & CEO, Aditya Kandoi, expressed the company's priorities in a statement. The existing Crysta IVF team and leadership will continue to lead the business, working closely with Moon Care, which will provide strategic guidance and mentorship.

Alvarez & Marsal acted as the exclusive advisor to the transaction. Mohit Khullar, Managing Director and Leader - Corporate Finance, Alvarez & Marsal India, commented on the transaction, noting that it underscores strong investor confidence in the healthcare services ecosystem and reinforces the growth potential of Crysta within the IVF segment.

Sanjeev Agarwal, Chairman, MMG Group, expressed the company's commitment to making fertility care more accessible and deeply technology-driven. He stated that Crysta IVF has earned the trust of thousands of families, and they see a strong opportunity to build on this foundation, expanding access to high-quality fertility treatments across the country while continuing to enhance patient experience and outcomes.

Key Highlights of the Transaction

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

EntityDetails
Deal ValueRs 100 crore
Transaction DateApril 9
BuyerMoon Care Private Limited (healthcare arm of MMG Group)
SellerRedcliffe Labs (fertility services business, Crysta IVF)
IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.